Search Results - "Purdie, Rob"
-
1
Antimicrobial resistance survivors: calling the world to action
Published in The Lancet (British edition) (01-06-2024)“…In some settings, the scarcity of data collection leads AMR rates to appear low and consequently research and intervention funding is not prioritised.1 At a…”
Get full text
Journal Article -
2
2516. Development of a de novo Patient-Reported Outcome (PRO) Measure to Assess the Impacts of Disseminated Coccidioidomycosis [Valley Fever] on Patients Living with the Condition
Published in Open forum infectious diseases (27-11-2023)“…Abstract Background Extrapulmonary or disseminated coccidioidomycosis (cocci) is a rare, severe form of fungal disease acquired by inhaling spores of…”
Get full text
Journal Article -
3
FDA Public Workshop Summary—Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs
Published in Clinical infectious diseases (10-06-2022)“…Abstract Coccidioidomycosis is a fungal disease endemic to the southwestern United States, Mexico, and Central and South America. Prevalence rates are…”
Get full text
Journal Article -
4
Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician Summit
Published in Open forum infectious diseases (01-06-2024)“…Recently, increasing focus on patient input into research and healthcare improvements has fostered expanded patient-centered advocacy efforts. This first…”
Get full text
Journal Article